CTRI/2012/07/002758
Completed
Phase 2
eoadjuvant chemotherapy with weekly paclitaxel and carboplatin followed by chemoradiation in locally advanced cervical carcinoma: a pilot study.
Dr BR Ambedkar Institute Rotary Cancer Hospital0 sites20 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecifiedHealth Condition 2: null- Squamous cell carcinoma of cervix, FIGO Stage IB2 to IVA.
- Sponsor
- Dr BR Ambedkar Institute Rotary Cancer Hospital
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Female patients of age between 18 and 70 years and performance status ECOG 0\-2 .
- •Squamous cell carcinoma and adenocarcinoma of cervix with histologically confirmed FIGO Stage IB2\-IVA and bidimensionally measurable lesion.
Exclusion Criteria
- •Undifferentiated, neuroendocrine, small cell carcinoma or rare histologies/ Prior chemotherapy or local therapy/ Significant co\-morbid conditions or abnormal haematological or biochemical parameters precluding chemotherapy/ Pregnancy and lactation/ Mental illness/
- •Previous or concomitant malignancies.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
eoadjuvant chemotherapy with Paclitaxel/Bevacizumab followed by FEC (5-Fluorouracil/Epirubicin/Cyclophosphamide) for triple negative operable primary breast cancerbreast cancerJPRN-UMIN000010228Department of Surgery, Division of Breast and Endocrine Surgery, St. Marianna University School of Medicine20
Active, not recruiting
Not Applicable
eoadjuvant chemotherapywith weekly docetaxel followed from concomitant docetaxel-RT in patients with high risk locally advancedprostate cancer - docrtpchigh risk locally advancedprostate cancerMedDRA version: 9.1Level: LLTClassification code 10060862Term: Prostate cancerEUCTR2008-003525-16-ITISTITUTI FISIOTERAPICI OSPITALIERI
Active, not recruiting
Phase 1
Preoperative chemotherapy with paclitaxel in women with HER2-negative high-risk breast cancerEUCTR2012-003481-41-ITFONDAZIONE MICHELANGELO - AVANZAMENTO DELLO STUDIO E CURA DEI TUMORI632
Active, not recruiting
Phase 1
Preoperative chemotherapy with paclitaxel in women with HER2-negative high-risk breast cancerEUCTR2012-003481-41-DEFONDAZIONE MICHELANGELO - AVANZAMENTO DELLO STUDIO E CURA DEI TUMORI632
Active, not recruiting
Phase 1
Preoperative chemotherapy with paclitaxel in women with HER2-negative high-risk breast cancerEUCTR2012-003481-41-ATFONDAZIONE MICHELANGELO - AVANZAMENTO DELLO STUDIO E CURA DEI TUMORI632